Delivery Order SPE2DB20D2104-SPE2DB24FS39E
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,777.00 Firm Fixed Price Delivery Order is for the supply of Entecavir 0.5 mg tablets. The contract has an ultimate completion date of November 29, 2021 and was awarded on November 26, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of Entecavir 0.5 mg tablets, valued at $3,000.82 with a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous prior...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Entecavir 0.5 mg tablets. The contract has a potential value of $5,038.26 and a completion date of January 5, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,241.40 firm fixed-price delivery order is for the supply of 4565785272 - Entecavir 0.5 mg Tablets (30s). The contract has an ultimate completion date of September 13, 2024 and was awarded on September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with...
- This federal contract award was issued by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $10,669.80 firm fixed-price delivery order is for the supply of 4,565,297 units of Entecavir 0.5 mg tablets. The contract has a final delivery date of July 31, 2024 and does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous indefinite delivery contracts by...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,739.04, is for the delivery of Entecavir 0.5mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,309.60 firm fixed-price contract is for the delivery of 4559908027 Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of February 13, 2023. AmerisourceBergen is a for-profit organization...
- This federal contract award, valued at $9,022.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. This is a firm-fixed-price delivery order contract with a completion date of September 30, 2024. The contract does not have a set-aside designation. As a large pharmaceutical distributor,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS39EDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,245.43 firm fixed price delivery order is for the supply of 30-count tablets of the pharmaceutical Entecavir 0.5 mg. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/5/24 |